Medicines Discovery Catapult Appoints Dr Francesca Sadler as Chief Commercial Officer and Dr Mike Strange as First Managing Director
Position
Managing Director
Company
Medicines Discovery Catapult
CheshireBiotechnologyHealth CareLife ScienceDescription
Medicines Discovery Catapult has expanded its executive team with the appointment of Dr Francesca Sadler as chief commercial officer and Dr Mike Strange as its first managing director. Francesca will lead MDC’s communications, commercial and business development teams, while Mike will be responsible for driving MDC’s organisational leadership and business strategy.
Quick answer
Medicines Discovery Catapult Appoints Dr Francesca Sadler as Chief Commercial Officer and Dr Mike Strange as First Managing Director (January 19, 2025). Medicines Discovery Catapult is based in Cheshire, England, United Kingdom.
- Who is the new Managing Director at Medicines Discovery Catapult?
- Medicines Discovery Catapult named Mike Strange Managing Director, announced January 19, 2025.
- What did Medicines Discovery Catapult announce on January 19, 2025?
- Medicines Discovery Catapult has expanded its executive team with the appointment of Dr Francesca Sadler as chief commercial officer and Dr Mike Strange as its first managing director. Francesca will lead MDC’s communications, commercial and business development teams, while Mike will be responsible for driving MDC’s organisational leadership and business strategy.
- What does Medicines Discovery Catapult do?
- Medicines Discovery Catapult (MDC) is an organization based in Cheshire, with a mission to support drug discovery innovators and drive investment in the life sciences sector.
- Where is Medicines Discovery Catapult based?
- Medicines Discovery Catapult is based in Cheshire, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Corundum Neuroscience (January 28, 2025), Supreme Group (January 8, 2025), Intas Pharmaceuticals Ltd (January 18, 2025) and Handtevy (January 20, 2025) also announced leadership changes within 45 days of Medicines Discovery Catapult.
Source: Fundz verified event record.
Other recent leadership changes in Life Science and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Corundum Neuroscience Appoints Itsik Francis as Head of Business Development (January 28, 2025)
- Supreme Group Announces Appointment of Krysta Pellegrino as Chief Growth Officer and Britt Thompson as Chief Commercial Officer (January 8, 2025)
- Intas Pharmaceuticals Appoints Dr. Pramod Kharwade as Vice President of Formulation and Development (January 18, 2025)
- Handtevy Appoints Dan Moran as Vice President of Education (January 20, 2025)
- Oragenics Appoints Janet Huffman as Interim Chief Executive Officer (January 17, 2025)
- Surgimate Appoints Kraig Brown as CEO (January 17, 2025)
Who to call at Medicines Discovery Catapult, and when
A new leader at Medicines Discovery Catapult brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Medicines Discovery Catapult raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Medicines Discovery Catapult, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Medicines Discovery Catapult. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Medicines Discovery Catapult changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Medicines Discovery Catapult changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.